| CRISPR Medicine | This is an overview of our news stories
Some of the best links we picked up around the internet
Last week, Intellia Therapeutics announced that it had received clearance to begin a clinical trial for NTLA-2002, an in vivo CRISPR therapy candidate...
New research on molecular genetic control of insect vectors of viral diseases led to the development of a CRISPR-based precision-guided sterile insect...
This week’s clinical update focuses on a newly posted Phase 1 clinical trial for a CRISPR-edited CAR-T therapy for relapsed or refractory CD19+...
A new electrochemical biosensor combines an aptamer capable of binding to pathogenic bacteria with CRISPR-Cas12a through a primer exchange reaction....
In this week’s clinical update, we take a look at a CRISPR-engineered T cell receptor-T cell therapy that is designed to treat all genetic subtypes of...
